WORLD
Lab Tests: Eli Lilly, Regeneron Antibody Therapies Lose out Against Omicron - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'Lab tests: Eli Lilly, Regeneron antibody therapies lose out against Omicron ...'
Lab tests: Eli Lilly, Regeneron antibody therapies lose out against Omicron https://t.co/haGi4pTK2N pic.twitter.com/CpDTYuwqze— Reuters (@Reuters) December 14, 2021
(The above story first appeared on LatestLY on Dec 15, 2021 03:56 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
